{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:38:48Z","timestamp":1790109528344,"version":"4.0.1"},"reference-count":156,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Liver transplantation (LT) has significantly transformed the prognosis of patients with end-stage liver disease and hepatocellular carcinoma (HCC). The traditional epidemiology of liver diseases has undergone a remarkable shift in indications for LT, marked by a decline in viral hepatitis and an increase in metabolic dysfunction-associated steatotic liver disease (MASLD), along with expanded indications for HCC. Recent advancements in surgical techniques, organ preservation and post-transplant patients\u2019 management have opened new possibilities for LT. Conditions that were historically considered absolute contraindications have emerged as potential new indications, demonstrating promising results in terms of patient survival. While these expanding indications provide newfound hope, the ethical dilemma of organ scarcity persists. Addressing this requires careful consideration and international collaboration to ensure equitable access to LT. Multidisciplinary approaches and ongoing research efforts are crucial to navigate the evolving landscape of LT. This review aims to offer a current overview of the primary emerging indications for LT, focusing on acute-on-chronic liver failure (ACLF), acute alcoholic hepatitis (AH), intrahepatic and perihilar cholangiocarcinoma (i- and p-CCA), colorectal liver metastasis (CRLM), and neuroendocrine tumor (NET) liver metastases.<\/jats:p>","DOI":"10.3390\/medicina60030412","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T06:14:22Z","timestamp":1709100862000},"page":"412","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evolution of Liver Transplantation Indications: Expanding Horizons"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0326-7088","authenticated-orcid":false,"given":"Sara","family":"Battistella","sequence":"first","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-9004","authenticated-orcid":false,"given":"Marco","family":"Grasso","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7622-6051","authenticated-orcid":false,"given":"Elisa","family":"Catanzaro","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-6625","authenticated-orcid":false,"given":"Francesca","family":"D\u2019Arcangelo","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Corr\u00e0","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Germani","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-6520","authenticated-orcid":false,"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-7178","authenticated-orcid":false,"given":"Alberto","family":"Zanetto","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-2038","authenticated-orcid":false,"given":"Alberto","family":"Ferrarese","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-1938","authenticated-orcid":false,"given":"Martina","family":"Gambato","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-191X","authenticated-orcid":false,"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-8941","authenticated-orcid":false,"given":"Francesco Paolo","family":"Russo","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16494","article-title":"OPTN\/SRTR 2019 Annual Data Report: Liver","volume":"21","author":"Kwong","year":"2021","journal-title":"Am. J. Transpl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2021.09.041","article-title":"Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT\/ELITA-ILTS)","volume":"76","author":"Russo","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 Annual Report of the European Liver Transplant Registry (ELTR)\u201450-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.28923","article-title":"Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy","volume":"65","author":"Flemming","year":"2017","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2018.06.010","article-title":"Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry","volume":"69","author":"Belli","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.3748\/wjg.v24.i38.4403","article-title":"Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study","volume":"24","author":"Ferrarese","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_8","unstructured":"WHO (2024, February 01). Hepatitis Fact Sheet 2021. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2012.10.016","article-title":"Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes","volume":"58","author":"Burra","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 67, 370\u2013398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"ref_15","first-page":"779","article-title":"Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma","volume":"157","author":"Tabrizian","year":"2022","journal-title":"JAMA Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajt.16978","article-title":"OPTN\/SRTR 2020 Annual Data Report: Liver","volume":"22","author":"Kwong","year":"2022","journal-title":"Am. J. Transpl."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ferrarese, A., Battistella, S., Germani, G., Russo, F.P., Senzolo, M., Gambato, M., Vitale, A., Cillo, U., and Burra, P. (2022). Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy. Medicina, 58.","DOI":"10.3390\/medicina58020290"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1920294","DOI":"10.1001\/jamanetworkopen.2019.20294","article-title":"Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014\u20132019","volume":"3","author":"Wong","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Di Martino, M., Vitale, A., Ferraro, D., Maniscalco, M., Pisaniello, D., Arenga, G., Falaschi, F., Terrone, A., Iacomino, A., and Galeota Lanza, A. (2022). Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes. Cancers, 14.","DOI":"10.3390\/cancers14205102"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41598-019-40543-4","article-title":"Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria","volume":"9","author":"Ravaioli","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/liv.13359","article-title":"mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib","volume":"37","author":"Meyer","year":"2017","journal-title":"Liver Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.3390\/curroncol29100593","article-title":"Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future","volume":"29","author":"Ruch","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/TP.0000000000003117","article-title":"Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival","volume":"104","author":"Lee","year":"2020","journal-title":"Transplantation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaoncol.2016.5116","article-title":"Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant","volume":"3","author":"Mehta","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-expanded criteria based on preoperative imaging","volume":"7","author":"Yao","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.hbpd.2020.06.011","article-title":"Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China","volume":"19","author":"Zhan","year":"2020","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.28643","article-title":"The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for hepatocellular carcinoma: A model including \u03b1-fetoprotein improves the performance of Milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.surg.2006.11.006","article-title":"A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma","volume":"141","author":"Yang","year":"2007","journal-title":"Surgery"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.sla.0000109146.72827.76","article-title":"Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma","volume":"239","author":"Cillo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1600-6143.2006.01719.x","article-title":"Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria","volume":"7","author":"Cillo","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep.27787","article-title":"Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation","volume":"62","author":"Toso","year":"2015","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2468-1253(17)30106-1","article-title":"Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: A retrospective cohort analysis","volume":"2","author":"Sasaki","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/SLA.0000000000001966","article-title":"Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story","volume":"265","author":"Halazun","year":"2017","journal-title":"Ann. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000106911","article-title":"HCC in living donor liver transplantation: Can we expand the Milan criteria?","volume":"25","author":"Kwon","year":"2007","journal-title":"Dig. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/SLA.0000000000001881","article-title":"A Novel Prognostic Index in Patients with Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score","volume":"264","author":"Lai","year":"2016","journal-title":"Ann. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1111\/j.1399-0012.2011.01572.x","article-title":"Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation","volume":"26","author":"Lai","year":"2012","journal-title":"Clin. Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/ajt.14549","article-title":"Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database","volume":"18","author":"Mehta","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1478-3231.2010.02425.x","article-title":"Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma","volume":"31","author":"Decaens","year":"2011","journal-title":"Liver Int."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2023). EASL Clinical Practice Guidelines on acute-on-chronic liver failure. J. Hepatol., 79, 461\u2013491.","DOI":"10.1016\/j.jhep.2023.04.021"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2018). EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol., 69, 406\u2013460.","DOI":"10.1016\/j.jhep.2018.08.009"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jhep.2021.06.017","article-title":"\u2018Equity\u2019 and \u2018Justice\u2019 for patients with acute-on chronic liver failure: A call to action","volume":"75","author":"Jalan","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100367","DOI":"10.1016\/j.jhepr.2021.100367","article-title":"Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process model","volume":"3","author":"Zhang","year":"2021","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1478-3231.2012.02790.x","article-title":"A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality","volume":"33","author":"Wlodzimirow","year":"2013","journal-title":"Liver Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/ajt.15852","article-title":"Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors","volume":"20","author":"Artzner","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/lt.26280","article-title":"Pretransplant Intensive Care Unit Management and Selection of Grade 3 Acute-on-Chronic Liver Failure Transplant Candidates","volume":"28","author":"Michard","year":"2022","journal-title":"Liver Transpl."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jhep.2019.10.013","article-title":"Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival","volume":"72","author":"Sundaram","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2021.03.030","article-title":"Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA\/EF-CLIF collaborative study (ECLIS)","volume":"75","author":"Belli","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/ajt.14198","article-title":"Adult Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure in High-Model for End-Stage Liver Disease Score Patients","volume":"17","author":"Moon","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/lt.23678","article-title":"Acute-on-chronic liver failure: Excellent outcomes after liver transplantation but high mortality on the wait list","volume":"19","author":"Finkenstedt","year":"2013","journal-title":"Liver Transpl."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/liv.13355","article-title":"Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation","volume":"37","author":"Levesque","year":"2017","journal-title":"Liver Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.3389\/ti.2022.10108","article-title":"Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure","volume":"35","author":"Schulz","year":"2022","journal-title":"Transpl. Int."},{"key":"ref_63","first-page":"22","article-title":"Current status of liver transplantation in Europe","volume":"82S","author":"Kabacam","year":"2020","journal-title":"Int. J. Surg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archinte.168.6.649","article-title":"Epidemiology of alcohol-related liver and pancreatic disease in the United States","volume":"168","author":"Yang","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cld.168","article-title":"Recent trends in the epidemiology of alcoholic liver disease","volume":"2","author":"Singal","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/jlts.2000.19027","article-title":"Liver transplantation for alcoholic liver disease: Bias, beliefs, 6-month rule, and relapse\u2014But where are the data?","volume":"6","author":"Beresford","year":"2000","journal-title":"Liver Transpl."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2005.06.003","article-title":"Corticosteroids for alcoholic hepatitis\u2014What\u2019s next?","volume":"43","author":"Mathurin","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.14309\/ajg.0000000000001596","article-title":"The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study","volume":"117","author":"Altamirano","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis","volume":"112","author":"Duvoor","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.3748\/wjg.v20.i40.14642","article-title":"Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement","volume":"20","author":"Testino","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dld.2016.12.027","article-title":"Common issues in the management of patients in the waiting list and after liver transplantation","volume":"49","author":"Burra","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Germani, G., D\u2019Arcangelo, F., Grasso, M., and Burra, P. (2023). Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation. Life, 13.","DOI":"10.3390\/life13091802"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/ajt.16936","article-title":"Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study","volume":"22","author":"Germani","year":"2022","journal-title":"Am. J. Transpl."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/msj.20135","article-title":"Controversies in the management of alcoholic liver disease","volume":"76","author":"Tan","year":"2009","journal-title":"Mt. Sinai J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.3748\/wjg.v21.i14.4423","article-title":"Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients","volume":"21","author":"Obed","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG Clinical Guideline: Alcohol-Associated Liver Disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States--A Single-Center Experience","volume":"16","author":"Im","year":"2016","journal-title":"Am. J. Transpl."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of Early Liver Transplantation for Patients with Severe Alcoholic Hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jamcollsurg.2017.12.044","article-title":"Liver Transplantation for Severe Alcoholic Hepatitis, Updated Lessons from the World\u2019s Largest Series","volume":"226","author":"Weeks","year":"2018","journal-title":"J. Am. Coll. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.6004\/jnccn.2009.0030","article-title":"Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis","volume":"7","author":"Chang","year":"2009","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2147\/OTT.S93629","article-title":"Intrahepatic cholangiocarcinoma: Current perspectives","volume":"10","author":"Buettner","year":"2017","journal-title":"Onco Targets Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MOT.0000000000000087","article-title":"Liver transplantation for cholangiocarcinoma: Current best practice","volume":"19","author":"DeOliveira","year":"2014","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","article-title":"Epidemiology and risk factors: Intrahepatic cholangiocarcinoma","volume":"6","author":"Gupta","year":"2017","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jso.23605","article-title":"Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: A population-based analysis","volume":"110","author":"Amini","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Beal, E.W., Cloyd, J.M., and Pawlik, T.M. (2020). Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles. J. Clin. Med., 10.","DOI":"10.3390\/jcm10010104"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajt.12591","article-title":"\u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?","volume":"14","author":"Sapisochin","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/lt.25737","article-title":"Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis","volume":"26","author":"Rayar","year":"2020","journal-title":"Liver Transpl."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/lt.22462","article-title":"Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma","volume":"18","author":"Panjala","year":"2012","journal-title":"Liver Transpl."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: A prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann. Surg."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/SLA.0000000000002624","article-title":"Surgical Treatment of Perihilar Cholangiocarcinoma: Resection or Transplant?","volume":"267","author":"Nagino","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0360-3016(97)00299-X","article-title":"External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma","volume":"39","author":"Foo","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","article-title":"The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer","volume":"28","author":"Alden","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1002\/lt.20965","article-title":"Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia","volume":"12","author":"Gores","year":"2006","journal-title":"Liver Transpl."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: Is pretreatment pathological confirmation of diagnosis necessary?","volume":"215","author":"Rosen","year":"2012","journal-title":"J. Am. Coll. Surg."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/lt.24975","article-title":"Con: Liver transplantation for expanded criteria malignant diseases","volume":"24","author":"Schaefer","year":"2018","journal-title":"Liver Transpl."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_115","first-page":"283","article-title":"Survival after liver resection in metastatic colorectal cancer: Review and meta-analysis of prognostic factors","volume":"4","author":"Kanas","year":"2012","journal-title":"Clin. Epidemiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jvir.2017.08.021","article-title":"Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control","volume":"29","author":"Shady","year":"2018","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/JTO.0000000000000632","article-title":"Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis at 1 Year","volume":"10","author":"Tselikas","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jnci\/djq456","article-title":"Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: An updated analysis","volume":"103","author":"Masi","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1072-7515(02)01498-9","article-title":"The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955\u20131967)","volume":"195","author":"Starzl","year":"2002","journal-title":"J. Am. Coll. Surg."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S2468-1253(21)00219-3","article-title":"Liver transplantation for non-resectable colorectal liver metastases: The International Hepato-Pancreato-Biliary Association consensus guidelines","volume":"6","author":"Bonney","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/endrev\/bnz004","article-title":"Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms","volume":"41","author":"Hofland","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases","volume":"15","author":"Frilling","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Shah","year":"2021","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","article-title":"Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: A nationwide survey analysis","volume":"50","author":"Ito","year":"2015","journal-title":"J. Gastroenterol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000151562","article-title":"Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France","volume":"89","author":"Mitry","year":"2009","journal-title":"Neuroendocrinology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","article-title":"Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation?","volume":"47","author":"Mazzaferro","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)","volume":"21","author":"Capdevila","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1067\/msy.2003.114","article-title":"Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: A 15-year single center prospective study","volume":"133","author":"Elias","year":"2003","journal-title":"Surgery"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.suronc.2012.05.001","article-title":"Surgical resection of hepatic metastases from neuroendocrine neoplasms: A systematic review","volume":"21","author":"Saxena","year":"2012","journal-title":"Surg. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","article-title":"Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival","volume":"197","author":"Sarmiento","year":"2003","journal-title":"J. Am. Coll. Surg."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000431379","article-title":"Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases","volume":"102","author":"Partelli","year":"2015","journal-title":"Neuroendocrinology"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Ka\u00e7maz, E., Heidsma, C.M., Besselink, M.G.H., Dreijerink, K.M.A., Kl\u00fcmpen, H.J., Nieveen van Dijkum, E.J.M., and Engelsman, A.F. (2019). Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8030403"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.surg.2017.05.006","article-title":"Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review","volume":"162","author":"Moris","year":"2017","journal-title":"Surgery"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/ASO.2006.03.071","article-title":"Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors","volume":"13","author":"Osborne","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","article-title":"Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: A 213-case European liver transplant registry study","volume":"257","author":"Klempnauer","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/ajt.13831","article-title":"The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors","volume":"16","author":"Mazzaferro","year":"2016","journal-title":"Am. J. Transplant."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1111\/ajt.17156","article-title":"Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria","volume":"22","author":"Maspero","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1245\/s10434-017-5839-x","article-title":"Management of Neuroendocrine Tumor Liver Metastases: Long-Term Outcomes and Prognostic Factors from a Large Prospective Database","volume":"24","author":"Fairweather","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e028596","DOI":"10.1136\/bmjopen-2018-028596","article-title":"Transplantation of high-risk donor livers after resuscitation and viability assessment using a combined protocol of oxygenated hypothermic, rewarming and normothermic machine perfusion: Study protocol for a prospective, single-arm study (DHOPE-COR-NMP trial)","volume":"9","author":"Berendsen","year":"2019","journal-title":"BMJ Open"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/TP.0000000000004280","article-title":"Improved Organ Utilization and Better Transplant Outcomes with In Situ Normothermic Regional Perfusion in Controlled Donation After Circulatory Death","volume":"107","author":"Oniscu","year":"2023","journal-title":"Transplantation"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/SLA.0000000000005428","article-title":"Liver Transplantation Outcomes from Controlled Circulatory Death Donors: SCS vs in situ NRP vs ex situ NMP","volume":"275","author":"Gaurav","year":"2022","journal-title":"Ann. Surg."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/ajt.16996","article-title":"Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors","volume":"22","author":"Patrono","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/ajt.17022","article-title":"Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers","volume":"22","author":"Bodewes","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2020.08.015","article-title":"Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence","volume":"73","author":"Line","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: A 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.22356","article-title":"Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations","volume":"17","author":"Pomfret","year":"2011","journal-title":"Liver Transpl."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/3\/412\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:06:22Z","timestamp":1760105182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/3\/412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":156,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["medicina60030412"],"URL":"https:\/\/doi.org\/10.3390\/medicina60030412","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]}}}